BromoCatch™ Ligands Usage Protocols

This protocol is intended as a guide only, for full experimental details please read the reference provided.

In Brief

BromoCatch™ is a covalent protein tagging system based on engineered bromodomains that selectively and rapidly react with an electrophilic ligand. This enables irreversible labeling of BromoCatch™ fusion proteins in live cells, fixed cells, or lysates.

BromoCatch™ Ligands include:

Reagent Handling & Reconstitution

Recommended reconstitution details:

ReagentCatalog No.Supplied AmountStock ConcentrationDMSO Reconstitution Volume
Biotin BromoCatch™ Ligand893950 µg1 mM55 µL
BromoCatch™ Control Ligand7300100 µg1 mM226 µL
BromoCatch™ Ligand, Alkyne894050 µg1 mM79 µL
Janelia Fluor® 525, BromoCatch™ Ligand899710 µg200 µM44 µL
Janelia Fluor® 585, BromoCatch™ Ligand899810 µg200 µM43 µL
Janelia Fluor® 635, BromoCatch™ Ligand893710 µg200 µM43 µL
Janelia Fluor® 549, BromoCatch™ Ligand893850 µg1 mM48 µL

Tips:

  • Spin down contents before opening
  • Store reconstituted stock at –20 °C protected from light
  • Avoid repeated freeze–thaw cycles
  • BromoCatch™ Control Ligand can be used at X concentration to compete with other BromoCatch™ probes in control experiments

Cell Lysate Labeling Protocol

Example data generated using H2B, generalizable protocol for your protein of interest (POI).

Materials & Reagents

  • HEK293-FT cells
  • pCMV POI-BromoCatch vector
  • DMEM, Optimem, FBS (10%)
  • TAMRA, BromoCatch™ Ligand (Cat. No. 8938)
  • DMSO (control)
  • RIPA buffer
  • Primary anti-H2B antibody (Rabbit)
  • Secondary antibody (IR800)
  • 6 or 12 well plates
  • Humidified incubator (5% CO₂, 37°C)
  • Trypsin
  • Western blot reagents

Protocol

  1. Transfection: Transfect HEK293-FT cells with the pCMV POI-BromoCatch vector using standard transfection reagents and incubate in a humidified incubator (5% CO₂, 37°C) for at least 16 hours.
  2. Cell Plating: Trypsinize transfected cells and plate them onto 6 or 12 well plates and allow cells to adhere for 16 hours.
  3. Treatment with Probe: Replace DMEM with Optimem + 10% FBS, containing either DMSO (control) or increasing concentrations of TAMRA, BromoCatch™ Ligand.
  4. Incubation: Incubate treated cells for 2 hours in a humidified incubator (5% CO₂, 37°C).
  5. Cell Washing: Gently wash cells with warm Optimem + 10% FBS media to remove excess probe.
  6. Cell Lysis: Lyse cells using RIPA buffer to extract proteins.
  7. Western Blotting & Membrane Transfer: Perform SDS-PAGE and transfer proteins onto a membrane.
  8. Fluorescence Imaging: Directly image the membrane using the TMR fluorescence channel.

Control: POI Antibody Staining (if required)

   9. Primary Antibody Staining: Incubate membrane with anti-H2B antibody.

  10. Secondary Antibody Staining: Apply IR800-conjugated secondary antibody for detection.

TAMRA probes for cell lysate experiments.

Figure 1. TAMRA probes for cell lysate experiments.

TAMRA, BromoCatch™ Ligand (Cat. No. 8938) specifically detects H2B-BromoCatch at 0.25 μM concentration of probe. The probe showed no unspecific binding in HEK293FT WT cells when incubated at up to 2.5 μM.

Live-Cell Labeling Protocol (Fluorescent Probes)

Materials & Reagents

  • U2-OS cells
  • pCMV POI-BromoCatch vector
  • DMEM medium
  • Optimem + 10% FBS
  • Humidified incubator (5% CO₂, 37°C)
  • DMSO
  • Janelia Fluor® 635, BromoCatch™ Ligand (Cat. No. 8937)
  • Hoechst 33342 (Cat. No. 5117)
  • Trypsin
  • Confocal microscope

Protocol

  1. Transfection: Transfect U2-OS cells with pCMV POI-BromoCatch vector using a suitable transfection reagent and incubate the cells in a humidified incubator (5% CO₂, 37°C) for at least 16 hours.
  2. Cell Plating: Trypsinise the transfected cells and plate them onto microscopy slides and allow cells to adhere for 16 hours under standard incubation conditions.
  3. Treatment with Fluorogenic Probe: Replace DMEM medium with Optimem + 10% FBS, supplemented with DMSO (control) or 200 nM Janelia Fluor® 635, BromoCatch™ Ligand.
  4. Probe Incubation: Incubate cells with the probe for up to 8 hours in a humidified incubator (5% CO₂, 37°C).
  5. Cell Washing & Staining: Gently wash cells 3 times with warm Optimem + 10% FBS and add Hoechst 33342 to each well and incubate for 30 minutes.
  6. Imaging: Perform confocal microscopy imaging to analyze probe fluorescence and nuclear staining.
Cellular validation of Janelia Fluor 635, BromoCatch Ligand using live-cell confocal microscopy

Figure 2. Cellular validation of Janelia Fluor® 635, BromoCatch™ Ligand using live-cell confocal microscopy.

Pulldown Protocol (Biotin BromoCatch™ Ligand)

Materials & Reagents

  • HEK293-FT cells
  • pCMV H2B-BromoCatch vector
  • DMEM, Optimem, FBS (10%)
  • Biotin BromoCatch™ Ligand (Cat. No. 8939)
  • DMSO (control)
  • RIPA buffer
  • Primary anti-POI antibody
  • Secondary antibody (IR800)
  • 6 or 12 well plates
  • Humidified incubator (5% CO₂, 37°C)
  • Trypsin
  • Western blot reagents

Protocol

  1. Transfection: Transfect HEK293-FT cells with the pCMV H2B-BromoCatch vector using standard transfection reagents and incubate in a humidified incubator (5% CO₂, 37°C) for at least 16 hours.
  2. Cell Plating: Trypsinize transfected cells and plate them onto 6 or 12 well plates and allow cells to adhere for 16 hours.
  3. Treatment with probe: Replace DMEM with Optimem + 10% FBS, containing either DMSO (control) or increasing concentrations of Biotin BromoCatch™ Ligand.
  4. Incubation: Incubate treated cells for 2 hours in a humidified incubator (5% CO₂, 37°C).
  5. Cell Washing: Gently wash cells with warm Optimem + 10% FBS media to remove excess probe.
  6. Cell Lysis: Lyse cells using RIPA buffer to extract proteins.
  7. Western Blotting & Membrane Transfer: Perform SDS-PAGE and transfer proteins onto a membrane.
  8. Streptavidin TMR antibody incubation: Image membrane using the TMR fluorescence channel.​

Control: POI Antibody Staining (if required)

   9. Primary Antibody Staining: Incubate membrane with Rabbit anti-H2B antibody.

  10. Secondary Staining: Apply IR800-conjugated secondary antibody for detection.

Biotin BromoCatch ligand probes for cell lysate experiments

Figure 3. Biotin probes for cell lysate experiments.

Biotin BromoCatch™ Ligand (Cat. No. 8939) specifically detects H2B-BromoCatch at 0.25 μM concentration of probe. The probe showed no unspecific binding in HEK293FT WT cells when incubated at up to 2.5 μM.

Click Chemistry Protocol (Alkyne BromoCatch™ Ligand)

  1. Label cells or protein with 250 nM–1 µM ligand.
  2. Perform CuAAC with azide-fluorophore, CuSO4, ligand, and sodium ascorbate.
  3. Incubate 30 min at RT, then wash thoroughly.
  4. Proceed to analysis depending on azide used (e.g. fluorescence etc.)

Plasmids 

To streamline adoption of the BromoCatch™ platform, we have a comprehensive suite of ready-to-use plasmids for mammalian expression of BromoCatch tagged proteins. These constructs are optimized for flexible cloning and high-level expression in a range of cell types, supporting both N- and C-terminal fusions to your protein of interest.

Each vector includes a BromoCatch domain flanked by flexible glycine-serine linkers (GSL) and multiple cloning sites, enabling modular insertion of target sequences. Options are available with or without N- or C-terminal His-tags for affinity purification, and with your choice of CMV or TK promoters for high or moderate expression, respectively. Vectors are available with puromycin or hygromycin B selection markers to suit diverse experimental workflows.

Whether you're performing live-cell imaging, pull-down assays, or proximity labeling, these plasmids provide a reliable and efficient starting point for generating BromoCatch tagged fusion proteins.

Catalog NumberBackboneInsert Design
RDEH-BC01CMV promoter, PuromycinN-term BromoCatch/GSL/cloning sites
RDEH-BC02CMV promoter, Puromycincloning sites/GSL/C-term BromoCatch
RDEH-BC03CMV promoter, PuromycinN-term His/ BromoCatch /GSL/cloning sites
RDEH-BC04CMV promoter, Puromycincloning sites/GSL/C-term BromoCatch /His
RDEH-BC05CMV promoter, Hygromycin BN-term BromoCatch /GSL/cloning sites
RDEH-BC06CMV promoter, Hygromycin Bcloning sites/GSL/C-term BromoCatch
RDEH-BC07CMV promoter, Hygromycin BN-term His/BromoCatch/GSL/cloning sites
RDEH-BC08CMV promoter, Hygromycin Bcloning sites/GSL/C-term BromoCatch/His
RDEL-BC01TK promoter, PuromycinN-term BromoCatch/GSL/cloning sites
RDEL-BC02TK promoter, Puromycincloning sites/GSL/C-term BromoCatch
RDEL-BC03TK promoter, PuromycinN-term His/BromoCatch/GSL/cloning sites
RDEL-BC04TK promoter, Puromycincloning sites/GSL/C-term BromoCatch/His
RDEL-BC05TK promoter, Hygromycin BN-term BromoCatch/GSL/cloning sites
RDEL-BC06TK promoter, Hygromycin Bcloning sites/GSL/C-term BromoCatch
RDEL-BC07TK promoter, Hygromycin BN-term His/BromoCatch/GSL/cloning sites
RDEL-BC08TK promoter, Hygromycin Bcloning sites/GSL/C-term BromoCatch/His

BromoCatch™ GFP Expression Plasmids are also available.

BromoCatch™ is a trademark of Bio-Techne Corporation.

Janelia Fluor® is a registered trademark of Howard Hughes Medical Institute.